300238 冠昊生物
已收盘 07-30 15:00:00
资讯
新帖
简况
股市必读：冠昊生物（300238）新发布《关于召开2026年第一次临时股东会的提示性公告》
证券之星 · 01:50
股市必读：冠昊生物（300238）新发布《关于召开2026年第一次临时股东会的提示性公告》
冠昊生物(300238)7月20日股东户数2.66万户，较上期增加0.93%
证券之星 · 07-29 17:38
冠昊生物(300238)7月20日股东户数2.66万户，较上期增加0.93%
冠昊生物：截至2026年7月20日，公司股东总户数为26,618
证券之星 · 07-29 16:09
冠昊生物：截至2026年7月20日，公司股东总户数为26,618
冠昊生物（300238）披露2026年第一次临时股东大会通知，7月17日股价下跌7.22%
证券之星 · 07-17
冠昊生物（300238）披露2026年第一次临时股东大会通知，7月17日股价下跌7.22%
冠昊生物：控股子公司QY-iHEP02注射液获临床试验默示许可
格隆汇 · 07-10
冠昊生物：控股子公司QY-iHEP02注射液获临床试验默示许可
每周股票复盘：冠昊生物（300238）股东户数减少652户至2.64万户
证券之星 · 06-21
每周股票复盘：冠昊生物（300238）股东户数减少652户至2.64万户
冠昊生物（300238）披露董事会延期换届的提示性公告，6月18日股价上涨1.84%
证券之星 · 06-18
冠昊生物（300238）披露董事会延期换届的提示性公告，6月18日股价上涨1.84%
冠昊生物(300238)6月10日股东户数2.64万户，较上期减少2.41%
证券之星 · 06-15
冠昊生物(300238)6月10日股东户数2.64万户，较上期减少2.41%
股市必读：冠昊生物（300238）5月22日董秘有最新回复
证券之星 · 05-25
股市必读：冠昊生物（300238）5月22日董秘有最新回复
冠昊生物：截至2026年5月20日，公司股东总户数为27,025
证券之星 · 05-22
冠昊生物：截至2026年5月20日，公司股东总户数为27,025
冠昊生物(300238)4月30日股东户数2.77万户，较上期减少1.36%
证券之星 · 05-07
冠昊生物(300238)4月30日股东户数2.77万户，较上期减少1.36%
每周股票复盘：冠昊生物（300238）股东户数减少395户
证券之星 · 05-03
每周股票复盘：冠昊生物（300238）股东户数减少395户
冠昊生物(300238)4月20日股东户数2.81万户，较上期减少1.39%
证券之星 · 04-29
冠昊生物(300238)4月20日股东户数2.81万户，较上期减少1.39%
图解冠昊生物一季报：第一季度单季净利润同比下降31.64%
证券之星 · 04-29
图解冠昊生物一季报：第一季度单季净利润同比下降31.64%
股市必读：冠昊生物(300238)股东户数2.81万户，较上期减少1.39%
证券之星 · 04-27
股市必读：冠昊生物(300238)股东户数2.81万户，较上期减少1.39%
冠昊生物：截至2026年4月20日，公司股东总户数为28,116
证券之星 · 04-24
冠昊生物：截至2026年4月20日，公司股东总户数为28,116
冠昊生物：本次向特定对象发行股票目前尚未定价
证券之星 · 04-20
冠昊生物：本次向特定对象发行股票目前尚未定价
冠昊生物（300238）披露2025年年度股东会决议公告，4月16日股价下跌0.97%
证券之星 · 04-16
冠昊生物（300238）披露2025年年度股东会决议公告，4月16日股价下跌0.97%
股市必读：冠昊生物（300238）4月10日披露最新机构调研信息
证券之星 · 04-13
股市必读：冠昊生物（300238）4月10日披露最新机构调研信息
冠昊生物(300238)3月31日股东户数2.85万户，较上期减少3.14%
证券之星 · 04-06
冠昊生物(300238)3月31日股东户数2.85万户，较上期减少3.14%
加载更多
公司概况
公司名称：
冠昊生物科技股份有限公司
所属行业：
专用设备制造业
上市日期：
2011-07-06
主营业务：
冠昊生物科技股份有限公司的主营业务是材料、药业、细胞三大业务。公司的主要产品是生物型硬脑（脊）膜补片、B型硬脑（脊）膜补片、无菌生物护创膜、艾瑞欧TM乳房补片、胸普外科修补膜片、安润可降解泪小管栓、欣比克本维莫德乳膏、细胞技术服务。报告期内，冠昊生物荣获国家专精特新“小巨人”称号。
发行价格：
18.20
{"stockData":{"symbol":"300238","market":"SZ","secType":"STK","nameCN":"冠昊生物","latestPrice":10.5,"timestamp":1785394980000,"preClose":10.91,"halted":0,"volume":5915800,"delay":0,"changeRate":-0.0376,"floatShares":265000000,"shares":265000000,"eps":0.0741,"marketStatus":"已收盘","change":-0.41,"latestTime":"07-30 15:00:00","open":10.82,"high":11.04,"low":10.47,"amount":63302000,"amplitude":0.0522,"askPrice":10.51,"askSize":118,"bidPrice":10.5,"bidSize":302,"shortable":0,"etf":0,"ttmEps":0.0741,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1785461400000},"marketStatusCode":5,"adr":0,"adjPreClose":10.91,"symbolType":"stock","openAndCloseTimeList":[[1785375000000,1785382200000],[1785387600000,1785394800000]],"highLimit":12,"lowLimit":9.82,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":265155701,"isCdr":false,"pbRate":4.99,"roa":"--","peRate":141.700405,"roe":"1.77%","epsLYR":0.09,"committee":0.369113,"marketValue":2784000000,"turnoverRate":0.0223,"status":1,"floatMarketCap":2784000000},"requestUrl":"/m/hq/s/300238","defaultTab":"news","newsList":[{"id":"2655807199","title":"股市必读：冠昊生物（300238）新发布《关于召开2026年第一次临时股东会的提示性公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2655807199","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2655807199?lang=zh_cn&edition=full","pubTime":"2026-07-31 01:50","pubTimestamp":1785433823,"startTime":"0","endTime":"0","summary":"截至2026年7月30日收盘，冠昊生物报收于10.5元，下跌3.76%，换手率2.23%，成交量5.92万手，成交额6330.2万元。当日关注点交易信息汇总：7月30日主力资金净流出422.26万元，占总成交额6.67%。公司公告汇总：冠昊生物将于2026年8月3日召开2026年第一次临时股东会，审议董事会换届选举等重要议案，股权登记日为7月27日。其中董事选举采用累积投票方式，独立董事候选人的任职资格需经深交所审核。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026073100001404.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0046","300238","BK0251","BK0042","BK0077","BK0086"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655865389","title":"冠昊生物(300238)7月20日股东户数2.66万户，较上期增加0.93%","url":"https://stock-news.laohu8.com/highlight/detail?id=2655865389","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2655865389?lang=zh_cn&edition=full","pubTime":"2026-07-29 17:38","pubTimestamp":1785317899,"startTime":"0","endTime":"0","summary":"证券之星消息，近日冠昊生物披露，截至2026年7月20日公司股东户数为2.66万户，较6月10日增加245.0户，增幅为0.93%。在医疗器械行业个股中，冠昊生物股东户数高于行业平均水平，截至7月20日，医疗器械行业平均股东户数为2.14万户。从股价来看，2026年6月10日至2026年7月20日，冠昊生物区间涨幅为1.84%，在此期间股东户数增加245.0户，增幅为0.93%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026072900029356.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300238","BK0086","BK0042","BK0077","BK0251","BK0046"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655185057","title":"冠昊生物：截至2026年7月20日，公司股东总户数为26,618","url":"https://stock-news.laohu8.com/highlight/detail?id=2655185057","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2655185057?lang=zh_cn&edition=full","pubTime":"2026-07-29 16:09","pubTimestamp":1785312549,"startTime":"0","endTime":"0","summary":"证券之星消息，冠昊生物(300238)07月29日在投资者关系平台上答复投资者关心的问题。投资者提问：请问：截止7月20日，公司的股东人数是多少？冠昊生物回复：尊敬的投资者您好！截至2026年7月20日，公司股东总户数为26,618。感谢您的关注与支持！本文数据来源于深圳证券交易所互动易，仅供参考不构成投资建议。责任编辑：刘浩然","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026072900024890.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0086","BK0042","300238","BK0077","BK0251","BK0046"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652289723","title":"冠昊生物（300238）披露2026年第一次临时股东大会通知，7月17日股价下跌7.22%","url":"https://stock-news.laohu8.com/highlight/detail?id=2652289723","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2652289723?lang=zh_cn&edition=full","pubTime":"2026-07-17 22:39","pubTimestamp":1784299151,"startTime":"0","endTime":"0","summary":"截至2026年7月17日收盘，冠昊生物报收于11.3元，较前一交易日下跌7.22%，最新总市值为29.96亿元。该股当日开盘12.15元，最高12.15元，最低11.12元，成交额达1.12亿元，换手率为3.65%。近日，冠昊生物科技股份有限公司披露《关于召开2026年第一次临时股东会的通知》。公告显示，公司将于2026年8月3日召开2026年第一次临时股东会，会议由董事会召集，现场会议地点为广州市黄埔区玉岩路12号公司会议室。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071700045113.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0042","BK0086","BK0046","300238","BK0077","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650185950","title":"冠昊生物：控股子公司QY-iHEP02注射液获临床试验默示许可","url":"https://stock-news.laohu8.com/highlight/detail?id=2650185950","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2650185950?lang=zh_cn&edition=full","pubTime":"2026-07-10 16:56","pubTimestamp":1783673799,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["BK0046","300238","BK0251","BK0077","BK0086","BK0042"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645095206","title":"每周股票复盘：冠昊生物（300238）股东户数减少652户至2.64万户","url":"https://stock-news.laohu8.com/highlight/detail?id=2645095206","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2645095206?lang=zh_cn&edition=full","pubTime":"2026-06-21 02:14","pubTimestamp":1781979253,"startTime":"0","endTime":"0","summary":"截至2026年6月18日收盘，冠昊生物报收于11.06元，较上周的10.99元上涨0.64%。本周，冠昊生物6月18日盘中最高价报11.46元。冠昊生物当前最新总市值29.33亿元，在医疗器械板块市值排名102/129，在两市A股市值排名4424/5206。股本股东变化股东户数变动截至2026年6月10日，冠昊生物股东户数为2.64万户，较5月20日减少652.0户，减幅为2.41%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062100000563.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0042","BK0086","BK0251","BK0046","BK0077","300238"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644848580","title":"冠昊生物（300238）披露董事会延期换届的提示性公告，6月18日股价上涨1.84%","url":"https://stock-news.laohu8.com/highlight/detail?id=2644848580","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2644848580?lang=zh_cn&edition=full","pubTime":"2026-06-18 22:27","pubTimestamp":1781792835,"startTime":"0","endTime":"0","summary":"截至2026年6月18日收盘，冠昊生物报收于11.06元，较前一交易日上涨1.84%，最新总市值为29.33亿元。公司于近日披露《关于董事会延期换届的提示性公告》。延期换届不影响公司正常运营，公司将积极推进换届工作并及时披露进展。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026061800042573.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0042","300238","BK0046","BK0086","BK0251","BK0077"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643274974","title":"冠昊生物(300238)6月10日股东户数2.64万户，较上期减少2.41%","url":"https://stock-news.laohu8.com/highlight/detail?id=2643274974","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2643274974?lang=zh_cn&edition=full","pubTime":"2026-06-15 17:47","pubTimestamp":1781516833,"startTime":"0","endTime":"0","summary":"证券之星消息，近日冠昊生物披露，截至2026年6月10日公司股东户数为2.64万户，较5月20日减少652.0户，减幅为2.41%。在医疗器械行业个股中，冠昊生物股东户数高于行业平均水平，截至6月10日，医疗器械行业平均股东户数为2.21万户。从股价来看，2026年5月20日至2026年6月10日，冠昊生物区间跌幅为16.06%，在此期间股东户数减少652.0户，减幅为2.41%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026061500022863.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300238","BK0042","BK0251","BK0046","BK0077","BK0086"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638230769","title":"股市必读：冠昊生物（300238）5月22日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2638230769","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2638230769?lang=zh_cn&edition=full","pubTime":"2026-05-25 03:59","pubTimestamp":1779652748,"startTime":"0","endTime":"0","summary":"截至2026年5月22日收盘，冠昊生物报收于12.89元，上涨1.58%，换手率1.36%，成交量3.61万手，成交额4619.9万元。董秘最新回复投资者： 请问截至2026年5月15日，公司股东数是多少？截至2026年5月20日，公司股东总户数为27,025。感谢您的关注与支持！当日关注点来自交易信息汇总：5月22日主力资金净流出208.79万元，散户资金净流入124.87万元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026052500001647.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0046","BK0042","BK0077","300238","BK0086","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637946803","title":"冠昊生物：截至2026年5月20日，公司股东总户数为27,025","url":"https://stock-news.laohu8.com/highlight/detail?id=2637946803","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2637946803?lang=zh_cn&edition=full","pubTime":"2026-05-22 16:24","pubTimestamp":1779438251,"startTime":"0","endTime":"0","summary":"证券之星消息，冠昊生物(300238)05月22日在投资者关系平台上答复投资者关心的问题。投资者提问：请问截至2026年5月15日，公司股东数是多少？冠昊生物回复：尊敬的投资者您好！截至2026年5月20日，公司股东总户数为27,025。感谢您的关注与支持！以上内容为证券之星据公开信息整理，不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026052200029547.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0046","BK0251","300238","BK0077","BK0042","BK0086"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633117591","title":"冠昊生物(300238)4月30日股东户数2.77万户，较上期减少1.36%","url":"https://stock-news.laohu8.com/highlight/detail?id=2633117591","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2633117591?lang=zh_cn&edition=full","pubTime":"2026-05-07 17:33","pubTimestamp":1778146437,"startTime":"0","endTime":"0","summary":"证券之星消息，近日冠昊生物披露，截至2026年4月30日公司股东户数为2.77万户，较4月20日减少382.0户，减幅为1.36%。在医疗器械行业个股中，冠昊生物股东户数高于行业平均水平，截至4月30日，医疗器械行业平均股东户数为2.21万户。从股价来看，2026年4月20日至2026年4月30日，冠昊生物区间跌幅为7.37%，在此期间股东户数减少382.0户，减幅为1.36%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026050700028982.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0086","BK0042","BK0046","BK0077","300238","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632775546","title":"每周股票复盘：冠昊生物（300238）股东户数减少395户","url":"https://stock-news.laohu8.com/highlight/detail?id=2632775546","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2632775546?lang=zh_cn&edition=full","pubTime":"2026-05-03 05:28","pubTimestamp":1777757296,"startTime":"0","endTime":"0","summary":"截至2026年4月30日收盘，冠昊生物报收于14.21元，较上周的14.45元下跌1.66%。本周，冠昊生物4月28日盘中最高价报14.71元。冠昊生物当前最新总市值37.68亿元，在医疗器械板块市值排名93/129，在两市A股市值排名4141/5200。业绩披露要点：2026年一季度，冠昊生物归母净利润1016.23万元，同比下降31.64%。股本股东变化股东户数变动截至2026年4月20日，冠昊生物股东户数为2.81万户，较3月31日减少395.0户，减幅为1.39%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026050300001242.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0042","BK0086","300238","BK0046","BK0251","BK0077"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631066599","title":"冠昊生物(300238)4月20日股东户数2.81万户，较上期减少1.39%","url":"https://stock-news.laohu8.com/highlight/detail?id=2631066599","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2631066599?lang=zh_cn&edition=full","pubTime":"2026-04-29 18:00","pubTimestamp":1777456812,"startTime":"0","endTime":"0","summary":"证券之星消息，近日冠昊生物披露，截至2026年4月20日公司股东户数为2.81万户，较3月31日减少395.0户，减幅为1.39%。在医疗器械行业个股中，冠昊生物股东户数高于行业平均水平，截至4月20日，医疗器械行业平均股东户数为2.2万户。从股价来看，2026年3月31日至2026年4月20日，冠昊生物区间涨幅为5.94%，在此期间股东户数减少395.0户，减幅为1.39%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042900056749.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300238","BK0077","BK0086","BK0042","BK0046","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631532504","title":"图解冠昊生物一季报：第一季度单季净利润同比下降31.64%","url":"https://stock-news.laohu8.com/highlight/detail?id=2631532504","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2631532504?lang=zh_cn&edition=full","pubTime":"2026-04-29 06:22","pubTimestamp":1777414950,"startTime":"0","endTime":"0","summary":"证券之星消息，冠昊生物2026年一季报显示，一季度公司主营收入9344.4万元，同比下降1.43%；归母净利润1016.23万元，同比下降31.64%；扣非净利润924.27万元，同比下降33.34%；负债率37.13%，投资收益-15.3万元，财务费用69.35万元，毛利率76.64%。财报数据概要请见下图:以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042900015115.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300238"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630337293","title":"股市必读：冠昊生物(300238)股东户数2.81万户，较上期减少1.39%","url":"https://stock-news.laohu8.com/highlight/detail?id=2630337293","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2630337293?lang=zh_cn&edition=full","pubTime":"2026-04-27 08:48","pubTimestamp":1777250891,"startTime":"0","endTime":"0","summary":"截至2026年4月24日收盘，冠昊生物报收于14.45元，下跌0.69%，换手率1.44%，成交量3.82万手，成交额5488.07万元。来自股本股东变化：截至4月20日股东户数环比下降1.39%，户均持股数量升至9431.0股。股本股东变化股东户数变动近日冠昊生物披露，截至2026年4月20日公司股东户数为2.81万户，较3月31日减少395.0户，减幅为1.39%。户均持股数量由上期的9300.0股增加至9431.0股，户均持股市值为14.47万元。董秘最新回复投资者： 请问截至2026年4月23日，公司股东数是多少？","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042700007739.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0086","BK0046","BK0042","BK0251","BK0077","300238"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629815704","title":"冠昊生物：截至2026年4月20日，公司股东总户数为28,116","url":"https://stock-news.laohu8.com/highlight/detail?id=2629815704","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2629815704?lang=zh_cn&edition=full","pubTime":"2026-04-24 16:12","pubTimestamp":1777018333,"startTime":"0","endTime":"0","summary":"证券之星消息，冠昊生物(300238)04月24日在投资者关系平台上答复投资者关心的问题。投资者提问：请问截至2026年4月23日，公司股东数是多少？冠昊生物回复：尊敬的投资者您好！截至2026年4月20日，公司股东总户数为28,116。感谢您的关注与支持！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042400048549.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300238","BK0251","BK0077","BK0042","BK0086","BK0046"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628074345","title":"冠昊生物：本次向特定对象发行股票目前尚未定价","url":"https://stock-news.laohu8.com/highlight/detail?id=2628074345","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2628074345?lang=zh_cn&edition=full","pubTime":"2026-04-20 16:45","pubTimestamp":1776674712,"startTime":"0","endTime":"0","summary":"证券之星消息，冠昊生物(300238)04月20日在投资者关系平台上答复投资者关心的问题。投资者提问：你好，咨询一下，公司4月15日股东会已通过定增议案，请问什么时候能确定定增价格。冠昊生物回复：尊敬的投资者您好！本次向特定对象发行股票目前尚未定价，最终发行价格将按照法律法规、规范性文件的相关规定及发行对象申购报价的情况确定。感谢您的关注与支持！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042000022123.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0086","BK0046","BK0042","BK0251","BK0077","300238"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627296592","title":"冠昊生物（300238）披露2025年年度股东会决议公告，4月16日股价下跌0.97%","url":"https://stock-news.laohu8.com/highlight/detail?id=2627296592","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2627296592?lang=zh_cn&edition=full","pubTime":"2026-04-16 17:38","pubTimestamp":1776332329,"startTime":"0","endTime":"0","summary":"截至2026年4月16日收盘，冠昊生物报收于15.3元，较前一交易日下跌0.97%，最新总市值为40.57亿元。该股当日开盘15.41元，最高15.42元，最低15.16元，成交额达7020.42万元，换手率为1.74%。冠昊生物于2026年4月16日披露《2025年年度股东会决议公告》。所有议案均获表决通过，无否决议案。出席会议股东共193人，代表有表决权股份总数的29.9234%。北京市天元律师事务所对本次会议出具法律意见书，认为会议召集、召开程序及表决结果合法有效。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026041600032094.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0086","BK0251","BK0077","BK0046","BK0042","300238"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627030651","title":"股市必读：冠昊生物（300238）4月10日披露最新机构调研信息","url":"https://stock-news.laohu8.com/highlight/detail?id=2627030651","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2627030651?lang=zh_cn&edition=full","pubTime":"2026-04-13 00:58","pubTimestamp":1776013090,"startTime":"0","endTime":"0","summary":"截至2026年4月10日收盘，冠昊生物报收于15.36元，上涨1.05%，换手率2.68%，成交量7.1万手，成交额1.1亿元。当日关注点来自交易信息汇总：4月10日主力与游资资金均呈净流出状态，散户资金净流入近900万元。公司股票价格受二级市场等多方面因素影响，公司始终致力做好生产经营管理工作，推动公司健康可持续发展，重视保护投资者尤其是中小投资者的利益。如有相关安排，公司将严格按照法律法规履行信息披露义务。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026041300000457.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","BK0086","BK0046","BK0077","300238","BK0042"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625782506","title":"冠昊生物(300238)3月31日股东户数2.85万户，较上期减少3.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2625782506","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2625782506?lang=zh_cn&edition=full","pubTime":"2026-04-06 17:02","pubTimestamp":1775466164,"startTime":"0","endTime":"0","summary":"证券之星消息，近日冠昊生物披露，截至2026年3月31日公司股东户数为2.85万户，较3月10日减少924.0户，减幅为3.14%。在医疗器械行业个股中，冠昊生物股东户数高于行业平均水平，截至3月31日，医疗器械行业平均股东户数为2.19万户。从股价来看，2026年3月10日至2026年3月31日，冠昊生物区间跌幅为9.44%，在此期间股东户数减少924.0户，减幅为3.14%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026040600002045.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0077","BK0086","BK0046","BK0251","300238","BK0042"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1785437435883,"stockEarnings":[{"period":"1week","weight":-0.026},{"period":"1month","weight":-0.0948},{"period":"3month","weight":-0.2611},{"period":"6month","weight":-0.3375},{"period":"1year","weight":-0.3895},{"period":"ytd","weight":-0.2419}],"compareEarnings":[{"period":"1week","weight":-0.0186},{"period":"1month","weight":-0.0708},{"period":"3month","weight":-0.0748},{"period":"6month","weight":-0.0761},{"period":"1year","weight":0.0523},{"period":"ytd","weight":-0.0414}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"冠昊生物科技股份有限公司","boardCode":"AI0035","boardName":"专用设备制造业","stockholders":"26618人(较上一季度增加0.93%)","perCapita":"9960股","listingDate":"2011-07-06","address":"广东省广州市黄埔区玉岩路12号","registeredCapital":"26515万元","survey":" 冠昊生物科技股份有限公司的主营业务是材料、药业、细胞三大业务。公司的主要产品是生物型硬脑（脊）膜补片、B型硬脑（脊）膜补片、无菌生物护创膜、艾瑞欧TM乳房补片、胸普外科修补膜片、安润可降解泪小管栓、欣比克本维莫德乳膏、细胞技术服务。报告期内，冠昊生物荣获国家专精特新“小巨人”称号。","listedPrice":18.2},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"冠昊生物(300238)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供冠昊生物(300238)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"冠昊生物,300238,冠昊生物股票,冠昊生物股票老虎,冠昊生物股票老虎国际,冠昊生物行情,冠昊生物股票行情,冠昊生物股价,冠昊生物股市,冠昊生物股票价格,冠昊生物股票交易,冠昊生物股票购买,冠昊生物股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"冠昊生物(300238)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供冠昊生物(300238)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}